Skip to main content

Table 2 Factors associated with severe depressive symptoms in the study population

From: Prevalence and factors associated with severe depressive symptoms in older west African people living with HIV

Variables

 

Univariable models

Multivariable model

% severe depressive symptomsa

OR (95% CI)*

p-value

aOR (95% CI)*

p-value

Age

  

0.71

  

 50–59 years old

17.4

1

   

 ≥ 60 years old

18.9

1.1 (0.6–2.0)

   

Gender

  

0.09

  

 Men

22.7

1

   

 Women

14.5

0.6 (0.4–1.1)

   

Education level

     

 No education

10.9

1

   

 Primary school

21.8

2.2 (0.9–5.2)

0.08

  

 Secondary school

21.9

2.1 (0.9–4.7)

0.07

  

 University & Tertiary Education

13.5

1.1 (0.3–3.6)

0.87

  

Marital Status

     

 Married/Cohabitating

19.3

1

   

 Widowed

13.1

0.7 (0.3–1.3)

0.23

  

 Divorced

25.9

1.6 (0.6–4.2)

0.33

  

 Never married

20.0

1.0 (0.4–2.3)

0.99

  

Employment status

  

0.11

 

0.01

 Currently employed

14.5

1

 

1

 

 Unemployed

23.9

1.9 (1.0–3.8)

0.04

2.8 (1.4–5.7)

0.003

 Retired

19.1

1.3 (0.6–2.8)

0.51

1.2 (0.5–2.6)

0.67

Duration of HIV infection

 [6–69[

9.6

1

   

 [69–108[

16.7

1.9 (0.8–4.8)

0.17

  

 [108–141[

19.7

2.3 (0.9–5.8)

0.07

  

  ≥ 141

24.4

3.2 (1.3–7.6)

0.01

  

Clinical disease stage

 A

14.0

1

   

 B

19.9

1.3 (0.6–2.7)

0.46

  

 C

18.7

1.2 (0.5–3.2)

0.67

  

Nadir CD4

  

< 0.0001

  

  > 200

11.2

1

   

  ≤ 200

22.0

2.1 (1.1–4.2)

   

CD4

  

0.36

  

  ≥ 500

15.9

1

   

  < 500

20.1

1.3 (0.7–2.3)

   

Viral load

  

0.002

  

 Undetectable

15.1

1

   

 Detectable

37.2

3.1 (1.5–6.3)

   

Initial ART combination

  

0.10

  

 3TC + TDF + EFV

12.2

1

   

 Other

19.8

1.8 (0.9–3.8)

   

Actual ART combination

  

0.06

  

 3TC + TDF + EFV

14.2

1

   

 Other

22.1

1.7 (0.9–3.1)

   

Non adherence to ART

(ref.: adherent)

38.5

3.1 (0.9–9.9)

0.06

  

Alcohol consumption

(ref.: no)b

28.0

1.9 (0.7–4.8)

0.18

  

Tobacco (current/former) (ref.: no)

31.6

2.5 (1.3–4.9)

0.01

2.6 (1.3–5.4)

0.01

Drug consumption (ref.: no)

33.3

1.9 (0.3–11.0)

0.45

  

BMI

  

0.01

 

0.01

Normal / underweight

22.7

1

 

1

 

 Overweight/obesity

5.9

0.4 (0.2–0.8)

 

0.4 (0.2–0.8)

 

Comorbidities

 No

16.2

1

   

 Only one

17.8

1.2 (0.6–2.3)

0.62

  

 More than one

21.6

1.7 (0.8–3.4)

0.18

  

History of trauma (ref.: no)

18.2

0.9 (0.3–3.1)

0.99

  

History of neurological disease (ref.: no)

22.9

2.3 (0.9–5.6)

0.07

  
  1. Abbreviations: aOR adjusted Odd Ratio, ART antiretroviral therapy, BMI Body Mass Index, CI Confident Interval, EFV Efavirenz, OR odd ratio, ref. Reference group, TDF Tenofovir, 3TC Lamivudine
  2. *results considered as significant (p < 0.05) (bold text)
  3. aCalculated after imputation of missing data
  4. bref.: no: means that the OR is computed taking this category “absence of this medical problem” as the reference group